Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Clinical
    • Critical Care
    • Procedures
    • COVID-19
  • Practice Management
    • Quality
    • Public Policy
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Learning Portal
    • The Hospital Leader Blog
    • From SHM
    • SIG Spotlight
    • Chapter Spotlight

An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Clinical
    • Critical Care
    • Procedures
    • COVID-19
  • Practice Management
    • Quality
    • Public Policy
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Learning Portal
    • The Hospital Leader Blog
    • From SHM
    • SIG Spotlight
    • Chapter Spotlight

Heart Failure

  • 1
    News

    FDA expands sacubitril/valsartan indication to embrace some HFpEF

    February 17, 2021

    The newly approved labeling for sacubitril/valsartan (Entresto) is simply for “chronic heart failure” but almost teasingly adds, “the benefits are most clearly evident” at below-normal LVEF.

  • 1
    News

    More Americans hospitalized, readmitted for heart failure

    February 16, 2021

    “We should be emphasizing the things we know work to reduce heart failure hospitalization, which is, number one, prevention.”

  • News

    Cardiac activity not uncommon after lifesaving measures stop

    February 5, 2021

    ECG and blood pressure monitoring identified resumption of cardiac activity in 14% of patients, all occurring in the 5 minutes after pulselessness.

  • 1
    News

    Newer iPhones disable implanted defibrillators

    February 1, 2021

    Some newer smartphones are equipped with magnets sufficiently powerful to disable an implanted cardiac defibrillator.

  • 1
    News

    Neprilysin, corin singled out for potential to guide heart failure therapy

    January 28, 2021

    Circulating neprilysin and corin concentrations, which correlate with outcomes, could possibly be assessed to guide heart failure therapy.

  • 1
    News

    Myocarditis by CMR may be rare after COVID-19 in elite athletes

    January 27, 2021

    Some supposed ‘myocarditis’ detected by MRI after COVID-19 in university varsity competitors might be normal heart muscle – normal for athletes, that is, propose researchers.

  • News

    Biomarker HF risk score envisioned as SGLT2 inhibitor lodestar in diabetes

    January 19, 2021

    Together, four “easily measured” biomarkers predicted 5-year heart failure risk in patients with diabetes or prediabetes, potentially identifying best candidates for SGLT2 inhibitor therapy, some say.

  • 1
    News

    Updated ACC decision pathway embraces new heart failure treatment strategies

    January 11, 2021

    The ACC’s updated decision pathway aims to close the substantial gap between current practice and unmet opportunities for inhibiting HFrEF progression.

  • 1
    News

    COVID-19 mortality in hospitalized HF patients: Nearly 1 in 4

    December 31, 2020

    In-hospital mortality was 24.2% for patients with HF hospitalized with COVID-19, as compared with 14.2% for individuals without HF who were hospitalized with COVID-19.

  • News

    Fracking sites tied to increased heart failure hospitalizations

    December 10, 2020

    The results were consistent and robust among more than 9,000 patients with heart failure in Pennsylvania, a state steeped in controversy over fracking.

Previous1 … 4 5 6 7 8 … 19Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
  • Copyright © 2000-2023 by the Society of Hospital Medicine and related companies. All rights reserved. ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences